Who invested in CardioMEMS?
CardioMEMS's investors include Boston Millennia Partners, Arboretum Ventures, Easton Capital, Medtronic and Foundation Medical Partners, and 10 more on record.
United States · Growth startup
10 rounds we have observed, with the 15 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$233Mraised across 10 rounds since 2001, from 10 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
Reported by sec.govSEC filing: $38M sold, first sale Feb 2010
Reported by onbiovc.comSEC filing: $22M sold, first sale Jun 2009
No investor was named in the report.
From a historical funding recordSEC filing: $1.2M sold, first sale Apr 2009
From a historical funding record
No investor was named in the report.
From a historical funding record
From a historical funding record
No investor was named in the report.
From a historical funding record
From a historical funding record
No investor was named in the report.
From a historical funding record
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
From historical deal records. Wrong? Tell us.
CardioMEMS's investors include Boston Millennia Partners, Arboretum Ventures, Easton Capital, Medtronic and Foundation Medical Partners, and 10 more on record.
CardioMEMS has raised $233M across 10 rounds since 2001.
CardioMEMS's most recent round was a Growth of $60M in Sept 2010.
Its most recent round, $60M in Sept 2010, is also its largest on record.
CardioMEMS's first round on record, in Nov 2003, was backed by Johnson & Johnson Development Corporation (JJDC), Flare Capital and Arboretum Ventures and 2 others.
CardioMEMS's latest named round is a Growth, in Sept 2010.
CardioMEMS is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.